Western blotting revealed decreased p-PI3K and p-AKT levels following curcumin treatment, supporting an inhibitory effect on the PI3K/AKT pathway.<h4>Conclusion</h4>These findings highlight RXRA as a candidate gene associated with cisplatin resistance-related programs in gastric cancer. The gene discussed is RXRA; the disease is gastric cancer.